Palisade Bio (PALI) Equity Ratio (2010 - 2026)
Palisade Bio (PALI) reported Equity Ratio of 0.96 for Q1 2026, up 46.77% year-over-year from 0.65 in Q1 2025, and down 0.8% on a QoQ basis from 0.96 in Q4 2025.
Palisade Bio (PALI) has 17 years of Equity Ratio data on file, last reported at 0.96 in Q1 2026.
- Quarterly Equity Ratio rose 46.77% year-over-year to 0.96 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.96 (up 46.77% YoY) and the FY2025 annual result came in at 0.96, up 39.86% from the prior year.
- Equity Ratio declined to 0.96 in Q1 2026 per PALI's latest filing, from 0.96 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.96 in Q4 2025 and bottomed at 0.39 in Q2 2025.
- The 5-year median for Equity Ratio is 0.77 (2024), against an average of 0.73.
- The widest annual swing landed in 2022, when Equity Ratio surged 217.25%; it then slumped 49.16% in 2025.
- Tracing PALI's Equity Ratio over 5 years: stood at 0.79 in 2022, then increased by 1.69% to 0.81 in 2023, then retreated by 14.47% to 0.69 in 2024, then soared by 39.86% to 0.96 in 2025, then fell by 0.8% to 0.96 in 2026.
- Per Business Quant, the three latest PALI Equity Ratio figures stand at 0.96 (Q1 2026), 0.96 (Q4 2025), and 0.46 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.73 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.77 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.21 |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | 0.96 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.96 |
| Dec 31, 2025 | 0.96 |
| Sep 30, 2025 | 0.46 |
| Jun 30, 2025 | 0.39 |
| Mar 31, 2025 | 0.65 |
| Dec 31, 2024 | 0.69 |
| Sep 30, 2024 | 0.71 |
| Jun 30, 2024 | 0.77 |
| Mar 31, 2024 | 0.80 |
| Dec 31, 2023 | 0.81 |
| Sep 30, 2023 | 0.83 |
| Jun 30, 2023 | 0.86 |
| Mar 31, 2023 | 0.90 |
| Dec 31, 2022 | 0.79 |
| Sep 30, 2022 | 0.76 |
| Jun 30, 2022 | 0.54 |
| Mar 31, 2022 | 0.57 |
| Dec 31, 2021 | 0.59 |
| Sep 30, 2021 | 0.24 |
| Jun 30, 2021 | -0.63 |
| Mar 31, 2021 | -2.25 |
| Dec 31, 2020 | -5.50 |
| Sep 30, 2020 | -0.85 |
| Jun 30, 2020 | -0.68 |
| Mar 31, 2020 | -0.90 |
| Dec 31, 2019 | -1.27 |
| Sep 30, 2019 | 0.79 |
| Jun 30, 2019 | 0.56 |
| Mar 31, 2019 | 0.61 |
| Dec 31, 2018 | 0.79 |
| Sep 30, 2018 | 0.58 |
| Jun 30, 2018 | 0.67 |
| Mar 31, 2018 | 0.57 |
| Dec 31, 2017 | 0.61 |
| Sep 30, 2017 | 0.71 |
| Jun 30, 2017 | 0.58 |
| Mar 31, 2017 | 0.52 |
| Dec 31, 2016 | 0.50 |
| Sep 30, 2016 | -0.45 |
| Jun 30, 2016 | 0.06 |
| Mar 31, 2016 | -0.02 |
| Dec 31, 2015 | 0.33 |
| Sep 30, 2015 | 0.42 |
| Jun 30, 2015 | 0.55 |
| Mar 31, 2015 | 0.63 |
| Dec 31, 2014 | 0.59 |
| Sep 30, 2014 | 0.71 |
| Jun 30, 2014 | 0.74 |
| Mar 31, 2014 | 0.75 |
| Dec 31, 2013 | 0.43 |
| Sep 30, 2013 | 0.43 |
| Jun 30, 2013 | 0.32 |
| Mar 31, 2013 | 0.37 |
| Dec 31, 2012 | 0.80 |
| Sep 30, 2012 | 0.81 |
| Jun 30, 2012 | 0.63 |
| Mar 31, 2012 | 0.66 |
| Dec 31, 2011 | 0.41 |
| Sep 30, 2011 | 0.66 |
| Jun 30, 2011 | 0.84 |
| Dec 31, 2010 | 0.74 |